Skip to content

Comparison of the Ankle-Brachial Index Measurement Using a Specific Oscillometric Device vs. the Doppler Method

Comparison of the Ankle-Brachial Index Measurement Using a Specific Oscillometric Device vs. the Doppler Method

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03511612
Acronym
ABIOSCILLO
Enrollment
51
Registered
2018-04-30
Start date
2018-04-24
Completion date
2018-10-24
Last updated
2025-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease, Ankle Brachial Index, Doppler

Brief summary

Several methods are available to measure ankle brachial index (ABI) non-invasively. A recent scientific statement of the AHA considers the Doppler method as the reference. However because Doppler devices are not widely available in primary care, several attempts have been made to propose alternative methods, among whom oscillometric methods (automatic blood pressure machines) have attracted most attention. We hypothesize that: \- the diagnostic characteristics (i.e. sensitivity, specificity and AUC) of the oscillometric method would be very good as compared to the Doppler method. the oscillometric method would have better intra- and inter-observer reproducibilities as compared to the Doppler method.

Interventions

DIAGNOSTIC_TESTMeasure ankle brachial index (ABI)

This is a head-to-head comparison of 2 methods of determination of the ABI, taking the Doppler method as the standard and the oscillometric device AVP as the challenger

Sponsors

University Hospital, Limoges
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients referred with the suspicion of PAD, either because of: * symptoms in favor of intermittent claudication or more atypical pain when walking, or * asymptomatic individuals with the presence of at least 2 cardiovascular risk factors among the following : * Men \> 60 years or women \> 65 years * Regular cigarette smoking \>10 years, either current or in the past * Treated Type-2 diabetes \>5 years or Type-1 diabetes \>20 years * Treated hypertension * High blood cholesterol (either total-C \>240 mg/dl or LDL-C \>160 mg/dl) or treated by statins or other lipid-lowering agents * Documented history of coronary artery disease (history of PCI or CABG, or previous myocardial infarction, or CAD documented by coronary angiography) * Documented history of ischemic stroke

Exclusion criteria

* Patients with revascularized PAD * Patients with critical limb ischemia or leg/foot ulcers * Cardiac arrhythmia: Atrial fibrillation, atrial flutter, frequent supra- and ventricular ectopic beats * Patients under dialysis

Design outcomes

Primary

MeasureTime frameDescription
Measurement of the ABIDay of the inclusionMeasurement of the ABI, with Doppler method as reference

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026